<?xml version="1.0" encoding="UTF-8"?>
<p>Vaccinations are costly and usually take years to complete stringent animal and human trials before being made available to the public. However, in an epidemic or pandemic situation, the scientific community faces increasing pressure to rapidly respond with an effective vaccine. In previous epidemics such as Ebola, H1N1, SARS, and MERS, vaccine development was never completed due to the epidemic ending and funds being reallocated [
 <xref rid="B55-pathogens-09-00430" ref-type="bibr">55</xref>].
</p>
